Clinical Trial: A Research Study to Check the Safety of NNC9836-0001 When Given to Healthy Participants and Participants With Type 2 Diabetes

U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07896109) titled 'A Research Study to Check the Safety of NNC9836-0001 When Given to Healthy Participants and Participants With Type 2 Diabetes' on Oct. 19.

Brief Summary: The purpose of this clinical study is to determine if the study medicine NNC9836-0001 is safe and tolerable in healthy participants with overweight or obesity or who have type 2 diabetes (T2D). Participants will either get the study medicine NNC9836-0001 or placebo. Which treatment participants get is decided by chance. NNC9836-0001 is a new medicine aimed to treat type 2 diabetes.

Study Start Date: Oct. 21

Study Type: INTERVENTIONAL

Condition: Diabetes Mellitus, Type 2

Interv...